MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies

    G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)

    Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…
  • 2019 International Congress

    Does automated analysis of repeat DaTscan imaging aid diagnosis in suspected Lewy body disorders?

    F. Richardson, N. Vennart, P. Bartholomew, C. Mcdonald (Gateshead, United Kingdom)

    Objective: To establish if repeat SPECT imaging, using automated quantitative analysis, aids diagnosis in suspected Lewy Body Disorders (LBD). Background: Patients with suspected LBD are…
  • 2019 International Congress

    Cortical thickness analysis in Parkinson’s disease with urinary symptoms

    R. Roh, K. Kim, K. Koh (Seoul, Republic of Korea)

    Objective: This study aimed to identify the significant region which can be related to urinary symptoms in Parkinson’s disease using correlation analysis between non-motor symptoms…
  • 2019 International Congress

    Neuromelamin-MRI in patients with Pure Autonomic Failure

    O. Roman, P. Trujillo-Diaz, K. Hay, I. Biaggioni, C. Shibao, D. Claassen (Nashville, TN, USA)

    Objective: To assess the utility of neuromelanin-MRI (NM-MRI) methods in a prodromal alpha-synuclein disorder, Pure Autonomic Failure (PAF). Background: PAF is a peripheral alpha-synucleinopathy (AS)…
  • 2019 International Congress

    Prevalence and predisposing factors of Parkinson disease: A barangay community-based study in Quezon, Philippines

    MC. Rosales, DJ. Robles, RCN. Rodriguez, NB. Romana, JM. Rosales, G. Salazar, R. Rosales (Manila, Philippines)

    Objective: The researchers aim to determine the prevalence of the Parkinson Disease in a locale and explore the possible predisposing factors on the development of…
  • 2019 International Congress

    Pharmacokinetics of ABBV-951 Following 24-Hour Continuous Subcutaneous Infusion to Arm, Abdomen and Thigh

    M. Rosebraugh, P. Kym, W. Liu, M. Facheris, J. Benesh (North Chicago, IL, USA)

    Objective: Characterize levodopa pharmacokinetics (PK) and safety/tolerability of ABBV-951 in healthy volunteers at 3 different subcutaneous (SC) infusion sites: Arm, Abdomen and Thigh Background: As…
  • 2019 International Congress

    Parkinsonism and rapidly progressive dementia secondary to free-living ameba

    M. Rubio Hernandez, I. Rodriguez Leyva, M. Tello Zavala, A. Ortiz Alvarez, C. Gallegos Rios (San Luis Potosi, Mexico)

    Objective: Present an original case description of a patient with amebic meningoencephalitis. Background: Parkinsonism could be caused by degenerative disorders, brain injuries, drugs, toxins, and…
  • 2019 International Congress

    Motor and Non-Motor Symptom Burden in Parkinsonian and Cerebellar Phenotypes of Probable MSA

    M R. Rukmani, R. Yadav, P K. Pal, B. Bhaskarapillai, T N. Sathyaprabha (Bangalore, India)

    Objective: We aimed to assess the disease severity, non-motor symptoms and cardiac autonomic dysfunction in MSA phenotypes. Background: Multiple system atrophy (MSA) is an adult-onset,…
  • 2019 International Congress

    Abnormal metabolic brain network in multiple system atrophy and progressive supranuclear palsy: a replication on a new European cohort

    T. Rus, E. Rebec, P. Tomše, A. Studen, M. Grmek, C. Tang, D. Eidelberg, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify characteristic metabolic brain patterns specific for multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a new cohort of patients and…
  • 2019 International Congress

    A Lewy body disease of widely confirmed Lewy bodies in the cerebral cortexes including the occipital lobe without pathological changes in the hippocampal CA2/3 region

    M. Ryo, K. Hasegawa, I. Saitoh, S. Yagishita (Tokyo, Japan)

    Objective: We present Lewy body disease (LBD) showing unique neuropathological findings which are widely recognized Lewy bodies (LBs) in the cerebral cortexes including the occipital…
  • « Previous Page
  • 1
  • …
  • 1296
  • 1297
  • 1298
  • 1299
  • 1300
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley